scispace - formally typeset
Open AccessJournal Article

Perinatal development of drug-metabolizing enzyme activity in swine

Charles R. Short, +1 more
- 01 Aug 1970 - 
- Vol. 174, Iss: 2, pp 185-196
TLDR
In this article, the postnatal pattern of development in liver appeared to be biphasic in nature, with the greatest rate of increase in activity occurring during the first three to four weeks postpartum for all pathways except azo reduction (four to six weeks).
Abstract
Three oxidative, one reductive, one hydrolytic and one synthetic mechanism were studied in vitro utilizing preparations of liver and kidney obtained from pigs at weekly intervals from the 100th day of gestation through the 10th week postpartum. The oxidation of hexobarbital, l -amphetamine, p -nitroanisole and zoxazolamine, the hydrolysis of procaine and the glucuronidation of phenolphthalein occurred at very low rates in the tissues of the fetal and newborn pig, whereas the capacity for azo reduction of Neoprontosil by both tissues was evident at these ages. The postnatal pattern of development in liver appeared to be biphasic in nature, with the greatest rate of increase in activity occurring during the first three to four weeks postpartum for all pathways except azo reduction (four to six weeks). The reductive and hydrolytic mechanisms developed slowly in kidney after birth, whereas the capacity of this organ for oxidative metabolism or for glucuronic acid conjugation was insignificant at all ages. The content of glycogen in the liver at various ages after birth did not correlate well with the development of drug-metabolizing enzyme activity over the entire period studied. The CO-binding pigment (cytochrome P-450) of hepatic microsomes developed in parallel with the oxidative and reductive pathways, suggesting that this cytochrome may be rate-limiting to the development of these pathways.

read more

Citations
More filters
Journal ArticleDOI

Fetal and Neonatal Development of the Microsomal Monooxygenase System

TL;DR: In this paper, the fetal and neonatal development of the Microsomal Monooxygenase System (MOMOS) is discussed. But the authors do not discuss the role of the MOMOS in the development of infants.
Journal ArticleDOI

3,4‐Benzpyrene and N‐Methylaniline Metabolizing Enzymes in the Immature Human Foetus and Placenta

TL;DR: The metabolism of 3,4-benzpyrene and N-methylaniline in several tissues of the immature human foetus and in the human placenta was studied in vitro and suggested that they are drug metabolizing mixed-function oxidases.
Journal ArticleDOI

Prenatal and neonatal drug metabolism in man

TL;DR: The inconsistency of the results from animal fetuses and human fetuses shows that animal data have little relevance for the human fetus andequate pharmacokinetic information is a prerequisite for rational and safe drug treatment in the neonatal period.
Related Papers (5)